| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/18/2007 | CA2628308A1 Preparation of vaccine master cell lines using recombinant plant suspension cultures |
| 05/18/2007 | CA2628306A1 Immunostimulatory oligonucleotide-based compounds with glycerol-linked dinucleotides and modified guanosines at cpg and uses thereof |
| 05/18/2007 | CA2628282A1 Concurrent chemotherapy and immunotherapy |
| 05/18/2007 | CA2628254A1 Immunomodulatory properties of multipotent adult progenitor cells and uses thereof |
| 05/18/2007 | CA2628238A1 Compositions and methods for controlling tissue factor signaling specificity |
| 05/18/2007 | CA2627981A1 Reagents, methods and systems for selecting a cytotoxic antibody or variant thereof |
| 05/18/2007 | CA2626859A1 Tnf-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy |
| 05/18/2007 | CA2626810A1 Rod-shaped pleiomorphic non-motile gram-negative bacterium causing swollen kidney, spleen and heart in atlantic cod |
| 05/18/2007 | CA2626326A1 Antineoplastic combinations with mtor inhibitor, herceptin, and/or hki-272 |
| 05/18/2007 | CA2624905A1 Pqs and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 05/18/2007 | CA2624903A1 Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 05/17/2007 | US20070112179 Novel compounds |
| 05/17/2007 | US20070111942 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/17/2007 | US20070111931 Compositions and methods for promoting wound healing and tissue repair |
| 05/17/2007 | US20070111288 Biosynthesis of botulinium toxins by anaerobic fermentation of Clostridium botulin toxins |
| 05/17/2007 | US20070111266 Antibodies to murine zcytor17 ligand |
| 05/17/2007 | US20070111261 Antigens |
| 05/17/2007 | US20070111236 Streptococcus suis vaccines and diagnostic tests |
| 05/17/2007 | US20070111211 Integrated viral complexes, methods of production thereof, vaccines containing same and methods of use thereof |
| 05/17/2007 | US20070110809 Stabilised compositions |
| 05/17/2007 | US20070110774 Composition of restricted cancer cells which produce cancer cell proliferation suppressive materials, and uses thereof |
| 05/17/2007 | US20070110773 Composition of restricted cancer cells which produce cancer cell proliferation suppressive materials, and uses thereof |
| 05/17/2007 | US20070110772 polypeptide induces production of antibodies against protein on surface of zygotes to prevent infection of malaria from mosquito |
| 05/17/2007 | US20070110771 Immunogenic agent and pharmaceutical composition for use against homologous and heterologous pathogens |
| 05/17/2007 | US20070110770 combination of apolipoprotein E and an antigenic lipid administered to a subject for the purpose of inducing an immune response against the lipid and in immunization protocols |
| 05/17/2007 | US20070110769 Clostridial toxin derivatives and methods for treating pain |
| 05/17/2007 | US20070110768 Use of histones for the early diagnosis and/or preventive therapy of virally-infected living cells and a biochip for carrying out said diagnosis |
| 05/17/2007 | US20070110767 An immunogenic mixture of a vector that contains and expresses in vivo in a porcine host cell and a nucleic acid molecule or fragment thereof encoding a porcine circovirus type B antigen |
| 05/17/2007 | US20070110766 Proteinase K resistant surface protein of neisseria meningitidis |
| 05/17/2007 | US20070110765 Helicobacter pylori bacterioferritin |
| 05/17/2007 | US20070110764 Purified polypeptide having the amino acid sequence as set forth in SEQ ID NO: 6; DNA molecules that encode for proteins, BigL1, BigL2 and BigL3 in the Leptospira sp bacterium; diagnostic, therapeutic and vaccine applications; leptospirosis; spirochetesveterinary medicine; humans |
| 05/17/2007 | US20070110763 Polypeptides of streptococcus pyogenes |
| 05/17/2007 | US20070110762 Process for preparing polysaccharide-protein conjugate vaccines |
| 05/17/2007 | US20070110761 Protein purification means |
| 05/17/2007 | US20070110760 Methods and compositions targeting viral and cellular ITAM motifs, and use of same in identifying compounds with therapeutic activity |
| 05/17/2007 | US20070110759 Methods |
| 05/17/2007 | US20070110758 Method for inhibiting bacterial colonisation |
| 05/17/2007 | US20070110757 Antibody formulations having optimized aggregation and fragmentation profiles |
| 05/17/2007 | US20070110756 Method for modulating P53 activity via methylation |
| 05/17/2007 | US20070110755 Vascular endothelial cell growth factor antagonists |
| 05/17/2007 | US20070110754 Use of antagonist anti-cd40 antibodies for treatment of chronic lymphocytic leukemia |
| 05/17/2007 | US20070110753 Therapeutic agents for solid tumors |
| 05/17/2007 | US20070110752 Fibroblast growth factor receptors and methods for their use |
| 05/17/2007 | US20070110751 Compositions and methods for reducing infarct size |
| 05/17/2007 | US20070110750 Monoclonal antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence |
| 05/17/2007 | US20070110749 Centrosome proteins and uses thereof |
| 05/17/2007 | US20070110748 Fibronectin binding protein compositions and methods of use |
| 05/17/2007 | US20070110747 Binding agents |
| 05/17/2007 | US20070110746 Pharmaceutical composition for treatment of immunological disorders |
| 05/17/2007 | US20070110745 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 05/17/2007 | US20070110744 Lymphatic and blood endothelial cell genes |
| 05/17/2007 | US20070110743 Methods of protein production using anti-senescence compounds |
| 05/17/2007 | US20070110742 Recombinant peptide vector comprising the gene for treatment for autoimmune diseases |
| 05/17/2007 | US20070110724 DNA viral plasmid for use as gene transfer tool in genetic engineering and genic therapy; improved exogenous transcriptional expression |
| 05/17/2007 | US20070110718 System for treating and preventing breast cancer |
| 05/17/2007 | US20070110717 Dna vaccines against tumor growth and methods of use thereof |
| 05/17/2007 | US20070110716 Relationship of a specific metabolite to insulin resistance |
| 05/17/2007 | US20070110714 Medicinal composition for treatment of chronic hepatitis c |
| 05/17/2007 | US20070110673 Allergen peptide fragments and use thereof |
| 05/17/2007 | US20070110668 Modulation of Immunity and Ceacam1 Activity |
| 05/16/2007 | EP1785486A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/16/2007 | EP1785143A2 Vaccine composition against hepatitis c virus |
| 05/16/2007 | EP1784513A2 Fusion proteins comprising cd4 minimal modules and methods of use thereof |
| 05/16/2007 | EP1784493A2 Adenoviral vectors able to transduce apcs, potential use in immune response generation |
| 05/16/2007 | EP1784487A2 Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use |
| 05/16/2007 | EP1784428A2 Polysaccharide derivatives and uses in induction of an immune response |
| 05/16/2007 | EP1784426A2 Humanized anti-beta7 antagonists and uses therefor |
| 05/16/2007 | EP1784425A2 Anti-mcp-1 antibodies, compositions, methods and uses |
| 05/16/2007 | EP1784424A2 Eph receptor fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity |
| 05/16/2007 | EP1784419A2 Domains and epitopes of meningococcal protein nmb1870 |
| 05/16/2007 | EP1784416A2 Vaccines against aids comprising cmv/r - nucleic acid constructs |
| 05/16/2007 | EP1784224A2 Egfr kinase inhibitor combinations for treating respiratory and gastrointestinal disorders |
| 05/16/2007 | EP1784222A1 Nutritional composition comprising indigestible oligosaccharides |
| 05/16/2007 | EP1784221A2 Methods for the treatment and prevention of infection using anti-selectin agents |
| 05/16/2007 | EP1784220A2 Bacterial iron acquisition targets |
| 05/16/2007 | EP1784219A2 Stabilizing formulations |
| 05/16/2007 | EP1784218A1 Nutricional composition comprising immunoglobulins and oligosaccharides |
| 05/16/2007 | EP1784217A1 Treatment of hiv infection by t-cell modulation |
| 05/16/2007 | EP1784216A1 S100 protein inhibitors for treating leukemia |
| 05/16/2007 | EP1784215A1 1,4 o-linked saccharose derivatives for stabilizing antibodies or antibody derivatives |
| 05/16/2007 | EP1784214A2 Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine |
| 05/16/2007 | EP1784213A2 Improvements relating to meningococcal outer membrane vesicles |
| 05/16/2007 | EP1784212A2 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 05/16/2007 | EP1784211A2 Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae |
| 05/16/2007 | EP1784210A2 Carrier conjugates of gnrh-peptides |
| 05/16/2007 | EP1784209A1 Contraceptives based on sp22 and sp22 antibodies |
| 05/16/2007 | EP1784208A2 Use of a dna molecule as vaccine adjuvant |
| 05/16/2007 | EP1784160A1 Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers |
| 05/16/2007 | EP1599225B1 Compositions and methods for the generation of protective immune response against malaria |
| 05/16/2007 | EP1490407B1 Induction of anti-tumor ctl immunity through in vivo triggering of 4-1bb and/or cd40 |
| 05/16/2007 | EP1458883B1 Screening method for agents useful in treating diabetes |
| 05/16/2007 | EP1355928B1 Universal carrier for targeting molecules to gb3 receptor expressing cells |
| 05/16/2007 | EP1263484B1 Coating which promotes endothelial cell adherence |
| 05/16/2007 | EP1185664B1 CLONED GENONE OF INFECTIOUS HEPATITIS C VIRUS OF GENOTYPE 2a AND USES THEREOF |
| 05/16/2007 | EP1169340B1 Lantibiotic |
| 05/16/2007 | EP1140136B1 Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| 05/16/2007 | EP1115405B1 Use of tnf-alpha inhibitors for treating nerve root injury |
| 05/16/2007 | EP0930894B1 Induction of rev and tat specific cytotoxic t-cells for prevention and treatment of human immunodeficiency virus (hiv) infection |
| 05/16/2007 | CN1965086A Polyvalent viral vectors and a system for production thereof |
| 05/16/2007 | CN1965082A 人源化抗体 Humanized antibodies |